who makes the glp 1 drugs GLP-1 are often misunderstood. They are not “celebrity weight loss injections.” They are result of 40 years of metabolic research and may change how we treat obesity, diabetes, and aging Patients' Use GLP-1 Drugs for

arXiv Systematic Reviews / Meta-analyses A recent systematic review on type 3 diabetes draws together evidence of overlapping mechanistic pathways, supporting the idea that agents targeting insulin resistance (including GLP-1 RAs) might have benefit

This will ensure that you can use it for the least amount of time possible thereby reducing your risk of negative side effects

Low ineffective doses may deliver no benefit while still costing money

4 Also, GLP-1R agonism delays gastric emptying, 5 increases satiety, suppresses food intake, and reduces weight in humans

In the SURMOUNT-3 and SURMOUNT-4 studies, participants experienced significant weight losses with tirzepatide treatment, marking a mean weight loss of 26.6% and 26.0% over 84 and 88 weeks respectively [93,94]

Fibromyalgia patients with functional GI disorders should discuss this combination carefully with their provider before starting, as side effects may be more pronounced